Report Detail

Other Global Multiple Sclerosis Market Size, Status and Forecast 2019-2025

  • RnM3463336
  • |
  • 12 July, 2019
  • |
  • Global
  • |
  • 97 pages
  • |
  • QYResearch
  • |
  • Other

Global Multiple Sclerosis Market Size, Status and Forecast 2019-2025

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Multiple Sclerosis Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Injectable agents
      • 1.4.3 Oral agents
    • 1.5 Market by Application
      • 1.5.1 Global Multiple Sclerosis Market Share by Application (2014-2025)
      • 1.5.2 Hosptial
      • 1.5.3 Research
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Multiple Sclerosis Market Size
    • 2.2 Multiple Sclerosis Growth Trends by Regions
      • 2.2.1 Multiple Sclerosis Market Size by Regions (2014-2025)
      • 2.2.2 Multiple Sclerosis Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Multiple Sclerosis Market Size by Manufacturers
      • 3.1.1 Global Multiple Sclerosis Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Multiple Sclerosis Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Multiple Sclerosis Market Concentration Ratio (CR5 and HHI)
    • 3.2 Multiple Sclerosis Key Players Head office and Area Served
    • 3.3 Key Players Multiple Sclerosis Product/Solution/Service
    • 3.4 Date of Enter into Multiple Sclerosis Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Multiple Sclerosis Market Size by Type (2014-2019)
    • 4.2 Global Multiple Sclerosis Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Multiple Sclerosis Market Size (2014-2019)
    • 5.2 Multiple Sclerosis Key Players in United States
    • 5.3 United States Multiple Sclerosis Market Size by Type
    • 5.4 United States Multiple Sclerosis Market Size by Application

    6 Europe

    • 6.1 Europe Multiple Sclerosis Market Size (2014-2019)
    • 6.2 Multiple Sclerosis Key Players in Europe
    • 6.3 Europe Multiple Sclerosis Market Size by Type
    • 6.4 Europe Multiple Sclerosis Market Size by Application

    7 China

    • 7.1 China Multiple Sclerosis Market Size (2014-2019)
    • 7.2 Multiple Sclerosis Key Players in China
    • 7.3 China Multiple Sclerosis Market Size by Type
    • 7.4 China Multiple Sclerosis Market Size by Application

    8 Japan

    • 8.1 Japan Multiple Sclerosis Market Size (2014-2019)
    • 8.2 Multiple Sclerosis Key Players in Japan
    • 8.3 Japan Multiple Sclerosis Market Size by Type
    • 8.4 Japan Multiple Sclerosis Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Multiple Sclerosis Market Size (2014-2019)
    • 9.2 Multiple Sclerosis Key Players in Southeast Asia
    • 9.3 Southeast Asia Multiple Sclerosis Market Size by Type
    • 9.4 Southeast Asia Multiple Sclerosis Market Size by Application

    10 India

    • 10.1 India Multiple Sclerosis Market Size (2014-2019)
    • 10.2 Multiple Sclerosis Key Players in India
    • 10.3 India Multiple Sclerosis Market Size by Type
    • 10.4 India Multiple Sclerosis Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Multiple Sclerosis Market Size (2014-2019)
    • 11.2 Multiple Sclerosis Key Players in Central & South America
    • 11.3 Central & South America Multiple Sclerosis Market Size by Type
    • 11.4 Central & South America Multiple Sclerosis Market Size by Application

    12 International Players Profiles

    • 12.1 Abbvie
      • 12.1.1 Abbvie Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Multiple Sclerosis Introduction
      • 12.1.4 Abbvie Revenue in Multiple Sclerosis Business (2014-2019)
      • 12.1.5 Abbvie Recent Development
    • 12.2 Acorda Therapeutics
      • 12.2.1 Acorda Therapeutics Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Multiple Sclerosis Introduction
      • 12.2.4 Acorda Therapeutics Revenue in Multiple Sclerosis Business (2014-2019)
      • 12.2.5 Acorda Therapeutics Recent Development
    • 12.3 Bayer HealthCare
      • 12.3.1 Bayer HealthCare Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Multiple Sclerosis Introduction
      • 12.3.4 Bayer HealthCare Revenue in Multiple Sclerosis Business (2014-2019)
      • 12.3.5 Bayer HealthCare Recent Development
    • 12.4 Biogen
      • 12.4.1 Biogen Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Multiple Sclerosis Introduction
      • 12.4.4 Biogen Revenue in Multiple Sclerosis Business (2014-2019)
      • 12.4.5 Biogen Recent Development
    • 12.5 Genzyme (Sanofi)
      • 12.5.1 Genzyme (Sanofi) Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Multiple Sclerosis Introduction
      • 12.5.4 Genzyme (Sanofi) Revenue in Multiple Sclerosis Business (2014-2019)
      • 12.5.5 Genzyme (Sanofi) Recent Development
    • 12.6 GlaxoSmithKline
      • 12.6.1 GlaxoSmithKline Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Multiple Sclerosis Introduction
      • 12.6.4 GlaxoSmithKline Revenue in Multiple Sclerosis Business (2014-2019)
      • 12.6.5 GlaxoSmithKline Recent Development
    • 12.7 Merck Serono
      • 12.7.1 Merck Serono Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Multiple Sclerosis Introduction
      • 12.7.4 Merck Serono Revenue in Multiple Sclerosis Business (2014-2019)
      • 12.7.5 Merck Serono Recent Development
    • 12.8 Novartis
      • 12.8.1 Novartis Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Multiple Sclerosis Introduction
      • 12.8.4 Novartis Revenue in Multiple Sclerosis Business (2014-2019)
      • 12.8.5 Novartis Recent Development
    • 12.9 Pfizer
      • 12.9.1 Pfizer Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Multiple Sclerosis Introduction
      • 12.9.4 Pfizer Revenue in Multiple Sclerosis Business (2014-2019)
      • 12.9.5 Pfizer Recent Development
    • 12.10 Teva
      • 12.10.1 Teva Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Multiple Sclerosis Introduction
      • 12.10.4 Teva Revenue in Multiple Sclerosis Business (2014-2019)
      • 12.10.5 Teva Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Multiple sclerosis is a chronic, inflammatory medical condition, which results in demyelination, axonal transection, and neurodegeneration of the nerve cells of the brain and spinal cord. The immune system of the body targets the neurons within the CNS and damages the myelin sheath. It is a potentially debilitating disease, causing disruption in the communication and coordination functions of the body. The symptoms of multiple sclerosis differ widely, subject to the extent of damage and the number of neurons affected. Some of the symptoms observed are fatigue, numbness, spasticity, bladder dysfunction, cognitive changes, emotional changes, and depression. An individual with severe form of the disease can experience speech and movement problems.
      Nevertheless, the leading pharmaceutical companies operating in North America and Europe is shifting the focus on Asia-pacific region due to the growing demand for effective and economic MS treatment. . Pharmaceutical companies belong to developed regions are focusing on the commercialization of novel therapeutics having minimal side effects and economic pricing. Such product launch strategy would provide an opportunity for the pharmaceutical companies across developing economies. Furthermore, the market is majorly supplemented by increasing funding from government authorities for research and development.
      In 2018, the global Multiple Sclerosis market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Multiple Sclerosis status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Multiple Sclerosis development in United States, Europe and China.

      The key players covered in this study
      Abbvie
      Acorda Therapeutics
      Bayer HealthCare
      Biogen
      Genzyme (Sanofi)
      GlaxoSmithKline
      Merck Serono
      Novartis
      Pfizer
      Teva

      Market segment by Type, the product can be split into
      Injectable agents
      Oral agents

      Market segment by Application, split into
      Hosptial
      Research

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Multiple Sclerosis status, future forecast, growth opportunity, key market and key players.
      To present the Multiple Sclerosis development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Multiple Sclerosis are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


      Summary:
      Get latest Market Research Reports on Multiple Sclerosis . Industry analysis & Market Report on Multiple Sclerosis is a syndicated market report, published as Global Multiple Sclerosis Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Multiple Sclerosis market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,125.01
      4,687.52
      6,250.02
      3,471.71
      5,207.56
      6,943.42
      420,365.40
      630,548.10
      840,730.80
      268,573.11
      402,859.67
      537,146.22
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report